Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells

C. Ceresa, E. Giovannetti, J. Voortman, A. Laan, R.J. Honeywell, G. Giaccone, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1026-1036
JournalMolecular Cancer Therapeutics
Volume8
Issue number5
DOIs
Publication statusPublished - 2009

Cite this

@article{8ea20f5961594d00b887a6407c3964c2,
title = "Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells",
author = "C. Ceresa and E. Giovannetti and J. Voortman and A. Laan and R.J. Honeywell and G. Giaccone and G.J. Peters",
year = "2009",
doi = "10.1158/1535-7163.MCT-08-0700",
language = "Undefined/Unknown",
volume = "8",
pages = "1026--1036",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells

AU - Ceresa, C.

AU - Giovannetti, E.

AU - Voortman, J.

AU - Laan, A.

AU - Honeywell, R.J.

AU - Giaccone, G.

AU - Peters, G.J.

PY - 2009

Y1 - 2009

U2 - 10.1158/1535-7163.MCT-08-0700

DO - 10.1158/1535-7163.MCT-08-0700

M3 - Article

VL - 8

SP - 1026

EP - 1036

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 5

ER -